Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.06 is 99% below its 5-year average of 5.12, near the low end of its 5-year range (0.06–30.26).
As of the fiscal period ended Tuesday, June 30, 2026. 27.72% below its 12-month average of 0.08.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.06.
QUICK RATIO (ACID-TEST)
0.06
QUICK RATIO (ACID-TEST) AVG TTM
0.08
QUICK RATIO (ACID-TEST) AVG 3Y
0.19
QUICK RATIO (ACID-TEST) AVG 5Y
5.12
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-27.72%
CURRENT VS 3Y AVG
-67.24%
CURRENT VS 5Y AVG
-98.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.26
median of 790 covered companies
CURRENT VS SECTOR MEDIAN
-98.13%
vs the sector median at left
HCW Biologics Inc.
Market Cap
$559702.00
Quick Ratio (Acid-Test)
0.06
TTM Avg
0.08
3Y Avg
0.19
5Y Avg
5.12
Market Cap
$483178.00
Quick Ratio (Acid-Test)
3.59
TTM Avg
2.57
3Y Avg
4.32
5Y Avg
8.01
Market Cap
$665215.00
Quick Ratio (Acid-Test)
1.49
TTM Avg
0.81
3Y Avg
1.60
5Y Avg
1.33
Market Cap
$381125.00
Quick Ratio (Acid-Test)
0.78
TTM Avg
0.50
3Y Avg
0.69
5Y Avg
2.39
Market Cap
$791587.00
Quick Ratio (Acid-Test)
2.01
TTM Avg
1.73
3Y Avg
1.23
5Y Avg
1.09
Market Cap
$836359.00
Quick Ratio (Acid-Test)
4.64
TTM Avg
5.46
3Y Avg
4.98
5Y Avg
8.82
Market Cap
$859700.00
Quick Ratio (Acid-Test)
7.25
TTM Avg
5.33
3Y Avg
3.37
5Y Avg
2.65
Market Cap
$850879.00
Quick Ratio (Acid-Test)
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$855032.00
Quick Ratio (Acid-Test)
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCW Biologics Inc. (HCWB) | $559702.00 | 0.06 | 0.08 | 0.19 | 5.12 |
| XORTX Therapeutics Inc. (XRTX)vs › | $483178.00 | 3.59 | 2.57 | 4.32 | 8.01 |
| CDT Equity Inc. (CDT)vs › | $665215.00 | 1.49 | 0.81 | 1.60 | 1.33 |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | 0.78 | 0.50 | 0.69 | 2.39 |
| Ridgetech, Inc. (RDGT)vs › | $791587.00 | 2.01 | 1.73 | 1.23 | 1.09 |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $836359.00 | 4.64 | 5.46 | 4.98 | 8.82 |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $859700.00 | 7.25 | 5.33 | 3.37 | 2.65 |
| Bone Biologics Corporation (BBLG)vs › | $850879.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| Decoy Therapeutics Inc. (DCOY)vs › | $855032.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Sunshine Biopharma, Inc. (SBFM)vs › | $880215.00 | 3.30 | 2.21 | 2.83 | 5.86 |
Quick Ratio
0.06
Excludes inventory
Current Ratio
0.06
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.06 |
| 2026-03-31 | 0.09 |
| 2025-12-31 | 0.11 |
| 2025-09-30 | 0.06 |
| 2025-06-30 | 0.11 |
| 2025-03-31 | 0.07 |
| 2024-12-31 | 0.19 |
| 2024-09-30 | 0.07 |
| 2024-06-30 | 0.10 |
| 2024-03-31 | 0.46 |
| 2023-12-31 | 0.73 |
| 2023-09-30 | 2.56 |
| 2023-06-30 | 4.36 |
| 2023-03-31 | 6.62 |
| 2022-12-31 | 11.05 |
| 2022-09-30 | 12.52 |
| 2022-06-30 | 30.26 |
| 2022-03-31 | 26.74 |
| 2021-12-31 | 17.44 |
| 2021-09-30 | 17.36 |
| 2021-06-30 | 1.64 |
| 2021-03-31 | 6.69 |
| 2020-12-31 | 12.14 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
